Cohance Lifesciences Limited (BOM:543064)

Cohance Lifesciences Revenue

In the fiscal year ending March 31, 2026, Cohance Lifesciences had annual revenue of 23.03B INR with 92.27% growth. Cohance Lifesciences had revenue of 6.19B in the quarter ending March 31, 2026, a decrease of -26.33%.

• Revenue: 23.03B
• Revenue Growth: -14.01%
• P/S Ratio: 7.28
• Revenue / Employee: 18.72M
• Employees: 1,212
• Market Cap: 165.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	23.03B	11.05B	92.27%
Mar 31, 2025	11.98B	1.46B	13.91%
Mar 31, 2024	10.51B	-2.89B	-21.56%
Mar 31, 2023	13.40B	201.07M	1.52%
Mar 31, 2022	13.20B	3.11B	30.75%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error